The Role and Prospection of Breakthrough Therapy Drug Program in Drug Registration System

Yuan Lijia, Wang Xiaoyan, Yang Zhimin, Zhang Ning

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (9) : 973-983.

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (9) : 973-983. DOI: 10.16153/j.1002-7777.2022.09.002
Supervision Administration

The Role and Prospection of Breakthrough Therapy Drug Program in Drug Registration System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 36(9): 973-983 https://doi.org/10.16153/j.1002-7777.2022.09.002

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉